{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T15:00:51Z","timestamp":1790607651678,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,24]],"date-time":"2020-01-24T00:00:00Z","timestamp":1579824000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Science and Technology Development Fund of Shanghai Pudong New Area","award":["PKJ2016-Y42"],"award-info":[{"award-number":["PKJ2016-Y42"]}]},{"name":"Shanghai Engineering Research Center of Molecular Imaging Probes Program","award":["19DZ2282200"],"award-info":[{"award-number":["19DZ2282200"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.biopha.2020.109947","type":"journal-article","created":{"date-parts":[[2020,2,12]],"date-time":"2020-02-12T03:39:37Z","timestamp":1581478777000},"page":"109947","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Early prediction of tumor response after radiotherapy in combination with cetuximab in nasopharyngeal carcinoma using 99m Tc-duramycin imaging"],"prefix":"10.1016","volume":"125","author":[{"given":"Cheng","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojia","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianmin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koon Y.","family":"Pak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyi","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingjian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"29","key":"10.1016\/j.biopha.2020.109947_bib0005","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.1200\/JCO.2015.60.9347","article-title":"Management of nasopharyngeal carcinoma: current practice and future perspective","volume":"33","author":"Lee","year":"2015","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2020.109947_bib0010","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.canlet.2016.01.040","article-title":"Global trends in incidence and mortality of nasopharyngeal carcinoma","volume":"374","author":"Tang","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2020.109947_bib0015","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s40880-016-0103-5","article-title":"A new prognostic histopathologic classification of nasopharyngeal carcinoma","volume":"35","author":"Wang","year":"2016","journal-title":"Chin. J. Cancer"},{"issue":"6","key":"10.1016\/j.biopha.2020.109947_bib0020","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.hoc.2015.07.004","article-title":"Chemotherapy for nasopharyngeal carcinoma - current recommendation and controversies","volume":"29","author":"Sze","year":"2015","journal-title":"Hematol. Oncol. Clin. North Am."},{"issue":"6","key":"10.1016\/j.biopha.2020.109947_bib0025","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S1470-2045(15)70126-9","article-title":"Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis","volume":"16","author":"Blanchard","year":"2015","journal-title":"The Lancet Oncol."},{"issue":"3","key":"10.1016\/j.biopha.2020.109947_bib0030","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.radonc.2013.10.020","article-title":"Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: an analysis of survival and treatment toxicities","volume":"110","author":"Sun","year":"2014","journal-title":"Radiother. Oncol."},{"issue":"23","key":"10.1016\/j.biopha.2020.109947_bib0035","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1001\/jama.2017.7105","article-title":"Effect of first-line chemotherapy combined with cetuximab or bevacizumab on overall survival in patients with KRAS wild-type advanced or metastatic colorectal cancer: a randomized clinical trial","volume":"317","author":"Venook","year":"2017","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.biopha.2020.109947_bib0040","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3892\/ol.2014.2631","article-title":"p53, MDM2, eIF4E and EGFR expression in nasopharyngeal carcinoma and their correlation with clinicopathological characteristics and prognosis: a retrospective study","volume":"9","author":"Zhang","year":"2015","journal-title":"Oncol. Lett."},{"issue":"1","key":"10.1016\/j.biopha.2020.109947_bib0045","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/s12885-018-4268-y","article-title":"Anti-EGFR targeted therapy delivered before versus during radiotherapy in locoregionally advanced nasopharyngeal carcinoma: a big-data, intelligence platform-based analysis","volume":"18","author":"Peng","year":"2018","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.biopha.2020.109947_bib0050","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMoa053422","article-title":"Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck","volume":"354","author":"Bonner","year":"2006","journal-title":"New Engl. J. Med."},{"issue":"9","key":"10.1016\/j.biopha.2020.109947_bib0055","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.oraloncology.2015.06.008","article-title":"Weekly cetuximab concurrent with IMRT aggravated radiation-induced oral mucositis in locally advanced nasopharyngeal carcinoma: results of a randomized phase II study","volume":"51","author":"Xu","year":"2015","journal-title":"Oral Oncol."},{"issue":"6","key":"10.1016\/j.biopha.2020.109947_bib0060","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1002\/ijc.30819","article-title":"Cetuximab or nimotuzumab plus intensity-modulated radiotherapy versus cisplatin plus intensity-modulated radiotherapy for stage II-IVb nasopharyngeal carcinoma","volume":"141","author":"You","year":"2017","journal-title":"Int. J. Cancer"},{"issue":"5","key":"10.1016\/j.biopha.2020.109947_bib0065","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1200\/JCO.2015.63.1671","article-title":"Cetuximab and radiotherapy versus cisplatin and radiotherapy for locally advanced head and neck cancer: a randomized phase II trial","volume":"34","author":"Magrini","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.biopha.2020.109947_bib0070","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur. J. Cancer"},{"issue":"10","key":"10.1016\/j.biopha.2020.109947_bib0075","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1021\/bc3003309","article-title":"Biomarkers and molecular probes for cell death imaging and targeted therapeutics","volume":"23","author":"Smith","year":"2012","journal-title":"Bioconjugate Chem."},{"issue":"6","key":"10.1016\/j.biopha.2020.109947_bib0080","doi-asserted-by":"crossref","first-page":"559","DOI":"10.7150\/thno.11548","article-title":"Molecular imaging of apoptosis: from micro to macro","volume":"5","author":"Zeng","year":"2015","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.biopha.2020.109947_bib0085","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00259-007-0577-0","article-title":"Prognostic value of 99mTc-HYNIC annexin-V imaging in squamous cell carcinoma of the head and neck","volume":"35","author":"Loose","year":"2008","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"3","key":"10.1016\/j.biopha.2020.109947_bib0090","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s11307-014-0804-6","article-title":"[99mTc]annexin v-128 SPECT monitoring of splenic and disseminated listeriosis in mice: a model of imaging sepsis","volume":"17","author":"Hardy","year":"2015","journal-title":"Mol. Imaging Biol."},{"key":"10.1016\/j.biopha.2020.109947_bib0095","doi-asserted-by":"crossref","DOI":"10.1177\/1536012116685941","article-title":"Preclinical evaluation of (18)F-ML-10 to determine timing of apoptotic response to chemotherapy in solid tumors","volume":"16","author":"Demirci","year":"2017","journal-title":"Mol. Imaging"},{"issue":"17","key":"10.1016\/j.biopha.2020.109947_bib0100","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1158\/1078-0432.CCR-14-3176","article-title":"A systematic comparison of 18F-C-SNAT to established radiotracer imaging agents for the detection of tumor response to treatment","volume":"21","author":"Witney","year":"2015","journal-title":"Clin. Cancer Res."},{"issue":"13","key":"10.1016\/j.biopha.2020.109947_bib0105","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1007\/s00259-018-4098-9","article-title":"Clinical translation of [(18)F]ICMT-11 for measuring chemotherapy-induced caspase 3\/7 activation in breast and lung cancer","volume":"45","author":"Dubash","year":"2018","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"3","key":"10.1016\/j.biopha.2020.109947_bib0110","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00259-007-0624-x","article-title":"99mTc Hynic-rh-Annexin V scintigraphy for in vivo imaging of apoptosis in patients with head and neck cancer treated with chemoradiotherapy","volume":"35","author":"Hoebers","year":"2008","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"13","key":"10.1016\/j.biopha.2020.109947_bib0115","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1007\/s00259-015-3152-0","article-title":"(99m)Tc-Annexin A5 quantification of apoptotic tumor response: a systematic review and meta-analysis of clinical imaging trials","volume":"42","author":"Belhocine","year":"2015","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"5","key":"10.1016\/j.biopha.2020.109947_bib0120","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s00726-009-0386-9","article-title":"Lantibiotics as probes for phosphatidylethanolamine","volume":"41","author":"Zhao","year":"2011","journal-title":"Amino acids"},{"issue":"7","key":"10.1016\/j.biopha.2020.109947_bib0125","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.nucmedbio.2012.03.006","article-title":"A single-step kit formulation for the (99m)Tc-labeling of HYNIC-Duramycin","volume":"39","author":"Zhao","year":"2012","journal-title":"Nucl. Med. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2020.109947_bib0130","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.nucmedbio.2012.09.004","article-title":"Imaging of rat cerebral ischemia-reperfusion injury using(99m)Tc-labeled duramycin","volume":"40","author":"Zhang","year":"2013","journal-title":"Nucl. Med. Biol."},{"issue":"2","key":"10.1016\/j.biopha.2020.109947_bib0135","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.nucmedbio.2014.09.002","article-title":"The feasibility of imaging myocardial ischemic\/reperfusion injury using (99m)Tc-labeled duramycin in a porcine model","volume":"42","author":"Wang","year":"2015","journal-title":"Nucl. Med. Biol."},{"issue":"5","key":"10.1016\/j.biopha.2020.109947_bib0140","doi-asserted-by":"crossref","first-page":"805","DOI":"10.2967\/jnumed.115.168344","article-title":"Early prediction of tumor response to treatment: preclinical validation of 99mTc-duramycin","volume":"57","author":"Elvas","year":"2016","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.biopha.2020.109947_bib0145","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.nucmedbio.2018.07.003","article-title":"[(99m)Tc]Tc-duramycin, a potential molecular probe for early prediction of tumor response after chemotherapy","volume":"66","author":"Li","year":"2018","journal-title":"Nucl. Med. Biol."},{"issue":"8","key":"10.1016\/j.biopha.2020.109947_bib0150","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.2967\/jnumed.112.112490","article-title":"Whole-body imaging of high-dose ionizing irradiation-induced tissue injuries using 99mTc-duramycin","volume":"54","author":"Johnson","year":"2013","journal-title":"J. Nucl. Med."},{"issue":"1","key":"10.1016\/j.biopha.2020.109947_bib0155","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.nucmedbio.2014.08.010","article-title":"In vivo detection of hyperoxia-induced pulmonary endothelial cell death using (99m)Tc-duramycin","volume":"42","author":"Audi","year":"2015","journal-title":"Nucl. Med. Biol."},{"issue":"4","key":"10.1016\/j.biopha.2020.109947_bib0160","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1158\/1078-0432.CCR-18-1846","article-title":"Whole-body imaging of cell death provides a systemic, minimally invasive, dynamic, and near-real time indicator for chemotherapeutic drug toxicity","volume":"25","author":"Johnson","year":"2019","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.biopha.2020.109947_bib0165","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1007\/s11307-015-0852-6","article-title":"Characterization of [(99m)Tc]duramycin as a SPECT imaging agent for early assessment of tumor apoptosis","volume":"17","author":"Elvas","year":"2015","journal-title":"Mol. Imaging Biol."},{"issue":"5","key":"10.1016\/j.biopha.2020.109947_bib0170","first-page":"1397","article-title":"Cetuximab or nimotuzumab versus cisplatin concurrent with radiotherapy for local-regionally advanced nasopharyngeal carcinoma: a meta-analysis","volume":"19","author":"Liang","year":"2018","journal-title":"Asian Pac. J. Cancer Prevent."},{"issue":"3","key":"10.1016\/j.biopha.2020.109947_bib0175","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.bbalip.2012.08.016","article-title":"Formation and function of phosphatidylserine and phosphatidylethanolamine in mammalian cells","volume":"1831","author":"Vance","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.biopha.2020.109947_bib0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nucmedbio.2017.08.005","article-title":"[(99m)Tc]duramycin for cell death imaging: impact of kit formulation, purification and species difference","volume":"56","author":"Palmieri","year":"2018","journal-title":"Nucl. Med. Biol."},{"issue":"6","key":"10.1016\/j.biopha.2020.109947_bib0185","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.nucmedbio.2012.02.004","article-title":"Understanding the in vivo uptake kinetics of a phosphatidylethanolamine-binding agent (99m)Tc-Duramycin","volume":"39","author":"Audi","year":"2012","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.biopha.2020.109947_bib0190","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/4829180","article-title":"Ethanolamine and phosphatidylethanolamine: partners in health and disease","volume":"2017","author":"Patel","year":"2017","journal-title":"Oxid. Med. Cell. Longevity"},{"issue":"5","key":"10.1016\/j.biopha.2020.109947_bib0195","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/MBC.0b013e3283538875","article-title":"Duramycin exhibits antiproliferative properties and induces apoptosis in tumour cells","volume":"23","author":"Yates","year":"2012","journal-title":"Blood Coagulation Fibrinolysis"},{"issue":"6","key":"10.1016\/j.biopha.2020.109947_bib0200","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1158\/0008-5472.CAN-14-3494","article-title":"\u201c(Not) all (dead) things share the same breath\u201d: identification of cell death mechanisms in anticancer therapy","volume":"75","author":"Rello-Varona","year":"2015","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.biopha.2020.109947_bib0205","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ymeth.2013.02.011","article-title":"Determination of apoptotic and necrotic cell death in vitro and in vivo","volume":"61","author":"Vanden Berghe","year":"2013","journal-title":"Methods (San Diego, Calif.)"},{"key":"10.1016\/j.biopha.2020.109947_bib0210","doi-asserted-by":"crossref","first-page":"14.38.1","DOI":"10.1002\/0471142735.im1438s112","article-title":"Measuring apoptosis by microscopy and flow cytometry","volume":"112","author":"Hollville","year":"2016","journal-title":"Curr. Protoc. Immunol."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332220301372?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332220301372?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T14:48:02Z","timestamp":1790606882000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332220301372"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":42,"alternative-id":["S0753332220301372"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2020.109947","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early prediction of tumor response after radiotherapy in combination with cetuximab in nasopharyngeal carcinoma using 99m Tc-duramycin imaging","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2020.109947","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"109947"}}